Compare ADMA Biologics Inc (ADMA) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Vanguard Short Term Corporate Bond ETF — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Vanguard Short Term Corporate Bond ETF trades at $78.52. The key difference: ADMA Biologics Inc is trading nearer its 52-week high, Vanguard Short Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| ADMA | VCSH | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | Fixed Income |
52-Week High | $20.38 | $80.20 |
52-Week Low | $7.60 | $78.41 |
Enterprise Value | $2.29B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
